International call for research proposals on rare cancer drug development

Logo ATTRACT-call inclusief partnerlogo's


Five European anti-cancer charities are joining forces to stimulate international research on rare cancer drug development. The focus of this joint international call, the ATTRACT-Call, is on late phase (2/3) clinical trials on rare cancer drugs. Main goals are improving treatment for rare cancer patients and accelerate the development of drugs for rare cancers. We encourage researchers and clinicians from different countries to join forces, share knowledge, and collaborate.


Eligible for this call are multicenter, international phase 2/3 clinical trials on medicinal products for rare cancer treatment (including drug repurposing). Main applicants as well as research consortium partners should be located in one of the funding countries (Belgium, France, the Netherlands, Spain), with a minimum of 2 participating countries. Applicants (funding recipients) should be either Academic research groups or Clinical/Public health sector research groups. To support swift enrolment of study patients in clinical trials, inclusion centers outside of the funding countries may be included in the proposal. Public-private collaborations are accepted under strict conditions; note that private parties will not receive direct funding. Active patient participation in the set up and execution of the proposals is required. A strong regulatory and implementation strategy (incl. EMA advise, orphan designation, early HTA) is not obliged but highly recommended.

Requirements & Guidelines

All information regarding the ATTRACT-call, including background, scope, application requirements, preferences and recommendations, review procedure, timelines, funding conditions and estimated budgets can be found in the Guidelines for Applicants (available for download below). Please read them carefully.

The call will make use of a pre- and full proposal review process. Applications have to be submitted via the electronic application system of KWF: Grant Management System (GMS). Please note that registration in the system is required prior to submitting your application. It is recommended to register as soon as possible. Please check at least six weeks before the call deadline if your registration is approved. Instructions how to register are provided in the Instructions for GMS for Applicants (available for download below). A preview of the application form is also available for download, but please do not use it to submit. You have to apply via the form in GMS.


Indicative budget

The indicative total budget for the ATTRACT-call is up to 11.5 million euro, provided by the 5 collaborating funding organisations: FC AECC, Anticancer Fund, Fondation ARC, Kom Op Tegen Kanker, KWF Dutch Cancer Society. 


Call Open: 22 November 2022 12:00
Application deadline pre-proposal: 31 January 2023 12:00
Application deadline full-proposal: 27 June 2023 12:00
Rebuttal week: second half of September 2023
Grant decision: November 2023

Q&A Sessions

The ATTRACT consortium is hosting two Question & Answer sessions for applicants prior to closing of the pre-proposal, to answer any questions regarding the application. These are scheduled on December 1st 2022 and January 9th 2023. Please register for (one of) the webinars.